Skip to main content
Frontiers in Nutrition logoLink to Frontiers in Nutrition
. 2026 Mar 18;13:1791821. doi: 10.3389/fnut.2026.1791821

Uncovering non-linear dietary predictors of cardiovascular disease risk in older adults with periodontitis: a cross-sectional analysis

Jiefan Liu 1,†, Jinhao Wu 2,†, Xin Nie 1, Sunqiang Hu 1,†, Qiang Xu 1,*,†
PMCID: PMC13038995  PMID: 41929770

Abstract

Objective

This study investigates whether the chronic inflammatory state associated with periodontitis alters the relationship between habitual diet and cardiovascular disease (CVD) risk in older adults.

Methods

Data from three NHANES cycles (2009–2014) and the MyPyramid Equivalents Database (MPED) were integrated. To validate the generalizability of the findings, 183 older adults with periodontitis were included in an external validation study recruited from an independent hospital-based cohort. Feature selection was performed using correlation coefficients and the BORUTA algorithm. Six machine learning models were constructed, and SHAP and LIME algorithms were applied to interpret the associations between dietary trace elements, habitual food intake, and CVD risk.

Results

The XGBoost model demonstrated superior predictive performance (Validation AUC-ROC: 0.854 for NHANES, 0.889 for MPED). SHAP analysis identified key protective factors against CVD in older adults with periodontitis. In the exploratory NHANES model, the top predictors included theobromine, lycopene, total sugar, food folate, beta-cryptoxanthin, and magnesium. The MPED model identified meat, whole grains, cured meat, tomatoes, eggs, added sugars, and total fruits as strong protective factors. Crucially, multivariable logistic regression analysis of the external cohort confirmed that higher consumption of red meat (OR = 0.46, p = 0.013) and sweets (OR = 0.11, p < 0.001) remained significantly associated with reduced CVD risk, whereas traditional antioxidant sources like green vegetables did not show statistical significance in this specific inflammatory population.

Conclusion

Periodontitis-induced inflammation may partially invert dietary CVD risks, rendering higher intake of meat and sugars protective in this specific context. Interpretable XGBoost models reveal these non-linear effects, enabling more precise clinical nutrition guidance for older adults with periodontitis.

Keywords: aging, cardiovascular disease, dietary patterns, machine learning, periodontitis

Background

Periodontitis represents a critical public health burden in the aging population, characterized by chronic inflammation and the progressive destruction of tooth-supporting tissues. In the United States, approximately 62.3% of adults aged ≥65 years are affected, with nearly half exhibiting probing depths (PD) ≥ 4 mm and over 60% showing clinical attachment loss (AL) ≥ 5 mm (1). Globally, the prevalence remains alarmingly high; a systematic review in China reported pooled rates of 57.0% for PD ≥ 4 mm and 70.1% for AL ≥ 4 mm among older adults (1987–2015), with a noted male predilection (2). Aging exacerbates susceptibility to this condition through diminished healing capacity and immunosenescence (3). Crucially, periodontitis is not merely a localized oral pathology; it acts as a potent, modifiable amplifier of systemic cardiovascular disease (CVD) risk (4, 5). Recent evidence confirms that severe periodontitis significantly elevates the risk of cerebro-cardiovascular events, with hazard ratios reaching 1.16 in large-scale cohorts (4) and odds ratios (ORs) as high as 3.59 in cross-sectional analyses (5).

While dietary interventions are pivotal in CVD prevention, current guidelines are predominantly derived from general population cohorts. Substantial evidence demonstrates that diets rich in whole grains, fruits, legumes, and nuts reduce CVD mortality risk by 13–28%, whereas red and processed meats, as well as added sugars, are consistently associated with an increased risk of up to 23% (6, 7). Such protective effects are widely attributed to the synergistic action of dietary fiber, antioxidants, and key micronutrients—such as magnesium, selenium, and potassium—within the whole-food matrix (8–12). Meta-analyses confirm that a 100 mg/d increment in magnesium intake decreases stroke risk by 7% and heart failure by 22% (9). Conversely, deficiencies in selenium and zinc impair antioxidant defenses, thereby increasing CVD susceptibility (8).

However, a critical knowledge gap remains: conventional dietary recommendations may be ill-suited for older adults burdened by periodontitis-induced systemic inflammation. The complex interplay between whole-food nutrients, dosage, and CVD risk remains largely unexplored in this high-inflammation demographic. We hypothesize that the chronic systemic inflammation and oxidative stress accompanying periodontitis—driven by NLRP3 inflammasome activation and reactive oxygen species (ROS) accumulation (13, 14)—may fundamentally alter nutrient metabolism and bioavailability. Consequently, this inflammatory milieu could modify, or even invert, the established associations between diet and CVD outcomes. For a cohort where periodontitis prevalence approaches 70% (15), a re-evaluation of the dietary framework is imperative.

Standard linear statistical models, which underpin current dietary guidelines, are ill-equipped to capture the complex, non-linear interactions between nutrients and disease in such a pro-inflammatory state. To address this, the present study integrated Machine Learning (ML) models—specifically designed to resolve high-dimensional, non-linear data structures—using data from the National Health and Nutrition Examination Survey (NHANES) and the MyPyramid Equivalents Database (MPED). Our objectives were twofold: (i) to construct a robust predictive model for CVD risk in older adults (>50 years) with periodontitis; and (ii) to employ interpretable algorithms (SHAP, LIME) to identify key modifiable dietary factors and elucidate their non-linear contributions. Through this approach, we aim to uncover novel, precision-nutrition strategies to mitigate CVD risk in this vulnerable population.

Materials and methods

Study population

This study utilized data from three continuous cycles of the National Health and Nutrition Examination Survey (NHANES, 2009–2014), a nationally representative cross-sectional survey conducted by the National Center for Health Statistics (NCHS). From an initial pool of 30,468 participants, we established a final analytical sample of 2,734 older adults with confirmed periodontitis (Figure 1). Exclusion criteria were as follows: (1) age <50 years (n = 21,955); (2) no periodontal examination data or absence of periodontitis (n = 4,974); (3) missing data on CVD history (n = 25); (4) incomplete dietary recall data (n = 234); and (5) missing values for key covariates, including education, poverty income ratio (PIR), or smoking status (n = 546).

Figure 1.

Flowchart illustrating participant selection from NHANES 2009-2014, starting with thirty thousand four hundred sixty-eight individuals. Exclusions occurred for age under fifty, missing database information, undiagnosable periodontitis or comorbidities, and missing demographic or health data, resulting in final inclusion of two thousand seven hundred thirty-four participants.

Flowchart of participant inclusion.

Assessment of dietary exposures

Dietary intake was assessed using two 24-h dietary recall interviews (the first conducted in-person and the second by telephone) utilizing the USDA Automated Multiple-Pass Method. Micronutrient data were extracted from the NHANES Dietary Interview files. To estimate daily food group consumption, NHANES food codes were linked to the USDA MyPyramid Equivalents Database (MPED).

Diagnosis of periodontitis and cardiovascular disease

Periodontitis was diagnosed according to the CDC/AAP case definitions based on a full-mouth periodontal examination, which measured clinical attachment loss (AL) and probing depth (PD) at six sites per tooth for up to 28 teeth (15). CVD status was defined based on self-reported physician diagnoses of heart failure, coronary heart disease, angina, myocardial infarction, or stroke, as recorded in the Medical Conditions Questionnaire.

Covariates

We incorporated a comprehensive set of sociodemographic and clinical covariates, including age, sex, race/ethnicity, education level, family income-to-poverty ratio (PIR), body mass index (BMI), smoking status (never, former, or current), and alcohol consumption. Hypertension and diabetes were defined using a composite of self-reported diagnosis, medication use, and objective laboratory thresholds (HbA1c, fasting plasma glucose, or oral glucose tolerance test).

External clinical validation cohort

To verify the generalizability of the ML-derived findings, we conducted a cross-sectional validation study at at our department, from November 2025 to January 2026. This study was approved by the Ethics Committee of Wenzhou Medical University (Ethics Review No. 2026-011, School of Stomatology, Wenzhou Medical University). The inclusion criteria mirrored those of the NHANES dataset.

Dietary intake was assessed using a simplified semi-quantitative Food Frequency Questionnaire (SQ-FFQ). To ensure methodological validity while maintaining clinical feasibility, frequency categories were adapted from validated questionnaires used in the China Kadoorie Biobank (CKB) study (16). Participants reported their consumption frequency of key food items identified by our SHAP analysis using a standard 5-point scale (1 = Never/Rarely to 5 = Daily).

Statistical analysis

Baseline characteristics were compared using Student’s t-tests for continuous variables and Chi-square tests for categorical variables. For the external validation cohort, multivariable logistic regression models were constructed to calculate adjusted ORs and 95% confidence intervals for CVD risk, controlling for age, sex, smoking status, and periodontal severity. All analyses were performed using IBM SPSS 24.0 and R 4.3.0, with statistical significance defined as p < 0.05.

Machine learning model development and interpretation

A total of 90 features (46 NHANES micronutrients, 37 MPED components, 7 categorical variables) were considered. A multicolinerity issue was corrected by dropping features with Spearman |ρ| > 0.9. SMOTE was used to balance CVD outcome class imbalance. All variables were normalized. The importance of features was determined using the Boruta algorithm (500 iterations, random forest base); only” confirmed” features were used. The dataset was split 7:3 into training and validation sets. Six ML models were developed using MLR3: Random Forest, LightGBM, K-Nearest Neighbors, Naive Bayes, SVM, and XGBoost. Performance was assessed via accuracy, F-beta, AUC-ROC (primary), sensitivity, specificity, and AUC-PR, with 10-fold cross-validation. Differences among models were evaluated with ANOVA, Kruskal–Wallis. In order to probe whether the presence of periodontitis-induced inflammation linearly modifies the relationship between risk-nutrients and CVD outcomes, we then aimed to rank model interpretability using SHapley Additive exPlanations (SHAP) to see both global and interaction effects, and Local Interpretable Model-agnostic Explanations (LIME) to see local prediction transparency.

Results

Baseline characteristics

The final analytical sample comprised 2,734 older adults with periodontitis (mean age 63.89 ± 9.17 years), of whom 59.1% were female. CVD was identified in 334 participants (12.2%), who were significantly older than those without CVD (mean age 68.42 ± 9.26 years). Compared to the non-CVD group, participants with CVD consumed significantly less energy (p = 0.003), protein (p = 0.034), carbohydrates (p = 0.002), and total sugars (p = 0.002). Specific food group analysis revealed significantly lower intake of dark green vegetables (p = 0.003), meat (p = 0.039), added sugars (p = 0.002), and alcoholic beverages (p = 0.042) in the CVD group (Table 1).

Table 1.

Baseline demographic, clinical, and dietary characteristics of the study population (NHANES 2009–2014), stratified by cardiovascular disease (CVD) status.

Characteristic N Overall (n = 2,734) Non-CVD (n = 2,400) CVD (n = 334) P
Sexb, n (%) 2,734 <0.001
Female 1,617 (59.14%) 1,388 (57.83%) 229 (68.56%)
Male 1,117 (40.86%) 1,012 (42.17%) 105 (31.44%)
Agea, Mean ± SD 2,734 63.89 ± 9.17 63.26 ± 8.97 68.42 ± 9.26 <0.001
Race/ethnicityb, n (%) 2,734 <0.001
Mexican 407 (14.89%) 377 (15.71%) 30 (8.98%)
Other Hispanic 259 (9.47%) 236 (9.83%) 23 (6.89%)
Non-Hispanic White 1,167 (42.68%) 980 (40.83%) 187 (55.99%)
Non-Hispanic Black 685 (25.05%) 607 (25.29%) 78 (23.35%)
Other race 216 (7.90%) 200 (8.33%) 16 (4.79%)
Educationb, n (%) 2,734 0.603
<9th grade 372 (13.61%) 322 (13.42%) 50 (14.97%)
9–11th grade 427 (15.62%) 369 (15.38%) 58 (17.37%)
High school diploma/GED 644 (23.56%) 566 (23.58%) 78 (23.35%)
Some college/AA degree 749 (27.40%) 658 (27.42%) 91 (27.25%)
≥College graduate 542 (19.82%) 485 (20.21%) 57 (17.07%)
Family income to poverty ratioa, Mean ± SD 2,734 2.48 ± 1.58 2.52 ± 1.58 2.25 ± 1.52 0.003
BMIa, Mean ± SD 2,734 29.36 ± 6.32 29.16 ± 6.20 30.79 ± 6.99 <0.001
Smoking statusb, n (%) 2,734 0.683
No 2,192 (80.18%) 1,927 (80.29%) 265 (79.34%)
Yes 542 (19.82%) 473 (19.71%) 69 (20.66%)
Hypertensionb, n (%) 2,734 <0.001
No 1,277 (46.71%) 1,197 (49.88%) 80 (23.95%)
Yes 1,457 (53.29%) 1,203 (50.13%) 254 (76.05%)
Diabetesb, n (%) 2,734 <0.001
No 1,859 (68.00%) 1,674 (69.75%) 185 (55.39%)
Yes 609 (22.28%) 498 (20.75%) 111 (33.23%)
Energya, Mean ± SD 2,734 2,004.06 ± 908.50 2,020.34 ± 907.57 1,887.09 ± 907.93 0.003
Proteina, Mean ± SD 2,734 79.73 ± 41.06 80.23 ± 41.00 76.12 ± 41.39 0.034
Carbohydratea, Mean ± SD 2,734 239.81 ± 109.86 241.94 ± 109.78 224.46 ± 109.37 0.002
Total sugara, Mean ± SD 2,734 102.59 ± 65.93 103.67 ± 65.57 94.82 ± 68.02 0.002
Dietary fibera, Mean ± SD 2,734 17.40 ± 10.90 17.61 ± 11.08 15.93 ± 9.32 0.022
Added sugarsa, Mean ± SD 2,734 14.76 ± 13.60 14.93 ± 13.47 13.52 ± 14.46 0.002
Meata, Mean ± SD 2,734 1.60 ± 2.58 1.59 ± 2.62 1.66 ± 2.32 0.039
Dark green vegetablesa, Mean ± SD 2,734 0.14 ± 0.41 0.15 ± 0.42 0.09 ± 0.30 0.003
Food folatea, Mean ± SD 2,734 224.71 ± 154.37 228.77 ± 158.55 195.55 ± 116.28 <0.001
Magnesiuma, Mean ± SD 2,734 296.69 ± 145.70 300.41 ± 148.40 269.93 ± 121.50 0.001
Alcoholic beveragesa, Mean ± SD 2,734 0.73 ± 2.07 0.76 ± 2.10 0.55 ± 1.86 0.042
a

Student t-test.

b

Chi-square test.

SD, standard deviation; Full breakdown of dietary micronutrients and additional food groups is provided in Supplementary Table S1. Bold values indicate P < 0.05.

Feature selection for machine learning

To mitigate multicollinearity, features with Spearman correlation coefficients >0.9 were excluded, resulting in the removal of “Total Fat” and “Total Folate” from the NHANES dataset (Figures 2A,B), and “Legumes as Protein Foods” and “Refined Grains” from the MPED dataset (Figures 2C,D). Subsequent feature selection using the Boruta algorithm identified 54 NHANES micronutrients and 45 MPED food components as significantly associated with CVD risk (Figures 2E,F). These confirmed features were retained for model construction. The stability of Z-scores during the selection process is illustrated in Supplementary Figure S1.

Figure 2.

Six-panel scientific figure with four upper heatmaps labeled A through D showing variable correlation matrices, with red shading indicating the strength and direction of correlation among features listed on both axes; lower panels E and F display horizontal bar plots ranking feature importance scores by the SHAP method for two groups, highlighting key factors such as hypertension and family income; legend denotes confirmed and shadow decisions.

Feature selection and multicollinearity management. (A) NHANES dataset before removing collinearity; (B) NHANES dataset after removing collinearity; (C) MPED before removing collinearity; (D) MPED after removing collinearity; (E) Feature importance for the NHANES dataset; (F) Feature importance for the MPED dataset.

Model construction and evaluation

Comparative analysis of the six machine learning algorithms—visualized via performance heatmaps (Figure 3) and ROC curves (Figures 4A–D)—demonstrated that XGBoost achieved superior predictive performance across both datasets. For the NHANES dataset, the XGBoost model yielded a validation AUC-ROC of 0.854, with an accuracy of 0.790 and F-beta of 0.824 (Table 2). Training set metrics indicated robust model fitting without significant overfitting (Supplementary Table S2). Similarly, the model demonstrated high stability in the MPED dataset, achieving a validation AUC-ROC of 0.889, an accuracy of 0.823, and F-beta of 0.852 (Table 3; training metrics in Supplementary Table S3). Further benchmark analysis using Precision-Recall curves (Figures 4E–H) and statistical comparisons confirmed that the performance advantages of XGBoost over other models were statistically significant (p < 0.001; Supplementary Figures S2, S3).

Figure 3.

Four heatmaps compare six machine learning models (XGBoost, SVM, Naive Bayes, k-NN, LightGBM, Random Forest) across six evaluation metrics (Accuracy, F-Beta, AUC, Sensitivity, Specificity, Pr-AUC) with metric values color-coded from zero to one, labeled A, B, C, and D in the lower left of each panel. Each heatmap includes a legend indicating metric value.

Heatmaps comparing the performance of different machine learning models in NHANES and the MPED. (A) NHANES training set; (B) NHANES validation set; (C) MPED training set; (D) MPED validation set.

Figure 4.

Eight-panel figure showing ROC (Receiver Operating Characteristic) and PR (Precision-Recall) curves comparing the performance of six machine learning models: Random Forest, Light GBM, k-NN, Naive Bayes, SVM, and XGBoost. Panels A, B, C, and D display ROC curves, each labeled with sensitivity versus 1 minus specificity and model legend. Panels E, F, G, and H display PR curves, each labeled with sensitivity versus 1 minus specificity and the same model legend. Curves are color-coded and shaded to indicate model variability.

Comprehensive performance evaluation of six machine learning models. (A–D) Receiver operating characteristic curves illustrating the diagnostic ability of the classifiers. (A) NHANES training set; (B) NHANES validation set; (C) MPED training set; (D) MPED validation set. (E–H) Precision-recall curves evaluating model performance. (E) NHANES training set; (F) NHANES validation set; (G) MPED training set; (H) MPED validation set.

Table 2.

Benchmark comparison results for the NHANES validation set.

Model Accuracy F beta Area under the ROC curve Sensitivity Specificity Area under the PR curve
Random Forest 0.802 (0.772–0.833) 0.846 (0.820–0.872) 0.862 (0.839–0.885) 0.928 (0.905–0.951) 0.624 (0.567–0.682) 0.865 (0.826–0.904)
Light GBM 0.800 (0.781–0.818) 0.834 (0.817–0.851) 0.854 (0.836–0.872) 0.861 (0.822–0.899) 0.719 (0.677–0.760) 0.854 (0.816–0.893)
K-KNN 0.686 (0.661–0.712) 0.667 (0.630–0.705) 0.797 (0.772–0.823) 0.541 (0.489–0.593) 0.898 (0.867–0.930) 0.852 (0.823–0.882)
Naive Bayes 0.527 (0.492–0.562) 0.436 (0.387–0.485) 0.622 (0.581–0.664) 0.314 (0.267–0.362) 0.838 (0.799–0.876) 0.700 (0.653–0.746)
SVM 0.693 (0.660–0.725) 0.753 (0.725–0.781) 0.735 (0.708–0.762) 0.799 (0.761–0.837) 0.548 (0.473–0.622) 0.773 (0.724–0.822)
XGBoost 0.790 (0.771–0.809) 0.824 (0.804–0.844) 0.854 (0.832–0.875) 0.840 (0.812–0.868) 0.724 (0.678–0.771) 0.857 (0.820–0.894)
P <0.001a <0.001a <0.001b <0.001a <0.001a <0.001a
a

ANOVA test.

b

Kruskal-Wallis.

Table 3.

Benchmark comparison results for the MyPyramid Equivalents Database validation set.

Model Accuracy F beta Area under the ROC curve Sensitivity Specificity Area under the PR curve
Random Forest 0.819 (0.789–0.850) 0.859 (0.833–0.884) 0.882 (0.856–0.908) 0.939 (0.915–0.963) 0.650 (0.603–0.697) 0.891 (0.862–0.919)
Light GBM 0.817 (0.783–0.851) 0.848 (0.820–0.877) 0.885 (0.855–0.914) 0.873 (0.851–0.895) 0.738 (0.678–0.797) 0.899 (0.868–0.929)
K-KNN 0.700 (0.665–0.736) 0.689 (0.650–0.727) 0.804 (0.779–0.829) 0.567 (0.519–0.615) 0.889 (0.854–0.924) 0.848 (0.817–0.879)
Naive Bayes 0.557 (0.527–0.588) 0.508 (0.479–0.537) 0.654 (0.615–0.694) 0.390 (0.356–0.425) 0.800 (0.752–0.848) 0.720 (0.672–0.767)
SVM 0.712 (0.674–0.749) 0.761 (0.725–0.796) 0.770 (0.743–0.797) 0.784 (0.751–0.817) 0.610 (0.551–0.669) 0.800 (0.770–0.829)
XGBoost 0.823 (0.796–0.851) 0.852 (0.828–0.877) 0.889 (0.863–0.915) 0.872 (0.853–0.891) 0.756 (0.705–0.806) 0.899 (0.869–0.929)
P <.001a <.001a <.001b <.001a <.001a <.001a
a

ANOVA test.

b

Kruskal-Wallis.

SHAP and LIME interpretation of dietary predictors

To interpret the optimal XGBoost model, we applied SHAP and LIME algorithms. SHAP summary plots identified the top predictors of CVD risk. In the NHANES model, Theobromine, Lycopene, Total Sugar, Food Folate, Beta-cryptoxanthin, and Magnesium emerged as the strongest protective factors (Figure 5A). In the MPED model, Meat, Whole Grains, Cured Meat, Tomatoes, Eggs, Added Sugars, and Total Fruits were identified as key protective dietary components (Figure 5B). Individual-level predictions were visualized using Force plots, which illustrated how specific feature combinations shifted the baseline probability of being CVD-free (Figures 5C–F). SHAP dependence plots further elucidated the non-linear relationships between the top six influential features and CVD risk (Figures 5G,H).

Figure 5.

Composite scientific figure with eight labeled panels (A-H). Panels A and B display SHAP value beeswarm plots for nutrients and food items, showing feature impact and color gradients for feature importance. Panels C and E show force plots depicting individual prediction contributions for cases with and without comorbidities, differentiating feature impacts in blue and purple. Panels D and F are bar plots of SHAP feature importance by comorbidity status, listing top-ranking variables. Panels G and H present partial dependence plots for key nutrients and food groups, with curved lines and scatter points color-coded by feature value.

Multi-perspective interpretation of the XGBoost model using SHAP algorithms. (A,B) SHAP summary plots illustrating global feature importance. Features are ranked by descending importance on the y-axis. The x-axis represents the SHAP value (impact on model output). (A) NHANES; (B) MPED. (C–F) Individual-level explanations using force and waterfall plots for representative cases. (C) NHANES force plots; (D) NHANES waterfall plots; (E) MPED force plots; (F) MPED waterfall plots. (G,H) SHAP dependence plots depicting the non-linear relationships between the top six influential dietary features and CVD risk. (G) NHANES; (H) MPED.

Complementing this, LIME analysis provided local interpretability for individual predictions. For a representative CVD-free individual in the NHANES model (predicted probability 0.806), protective contributions were observed for specific normalized ranges of Theobromine, Saturated Fatty Acids, and Alpha-Tocopherol (Figure 6A). Similarly, in the MPED model (predicted probability 0.939), protective effects were driven by specific intake levels of Whole Grains, Dark Green Vegetables, and Eggs (Figure 6B).

Figure 6.

Two grouped panels labeled A and B each display horizontal bar charts and summary tables comparing dietary or nutritional variables between no comorbidities and comorbidities groups. Bar charts show weighted contributions of different foods or nutrients, visually contrasting red and blue bars for each group. Adjacent summary tables further clarify positive and negative contributions for both groups, using color coding to highlight differences in dietary factors associated with comorbidity status. Panel A focuses on nutrients, while panel B emphasizes food groups.

LIME-based interpretation of the best-performing machine learning model (A,B). NHANES; (B) MyPyramid Equivalents Database.

Validation in the independent clinical cohort

The baseline characteristics of the external validation cohort (n = 183) are detailed in Table 4. Consistent with the primary NHANES analysis, the CVD group exhibited a significantly higher prevalence of smoking (p = 0.028).

Table 4.

Demographic and dietary characteristics of older adults with periodontitis in the validation cohort (n = 183).

Variables Total (n = 183) Non-CVD (n = 154) CVD (n = 29) P
Agea, Mean ± SD 60.16 ± 6.28 59.81 ± 6.26 62.03 ± 6.11 0.080
Red meata, Mean ± SD 3.62 ± 0.63 3.67 ± 0.61 3.34 ± 0.72 0.029
Whole grainsa, Mean ± SD 3.49 ± 0.57 3.54 ± 0.57 3.24 ± 0.51 0.010
Processed meata, Mean ± SD 3.49 ± 0.69 3.63 ± 0.59 2.72 ± 0.70 <0.001
Tomatoesa, Mean ± SD 3.46 ± 0.64 3.49 ± 0.63 3.34 ± 0.72 0.277
Eggsa, Mean ± SD 3.61 ± 0.61 3.66 ± 0.56 3.34 ± 0.77 0.046
Sweetsa, Mean ± SD 3.49 ± 0.63 3.62 ± 0.53 2.79 ± 0.68 <0.001
Fruitsa, Mean ± SD 3.59 ± 0.76 3.64 ± 0.75 3.31 ± 0.76 0.030
Citrusa, Mean ± SD 3.48 ± 0.78 3.49 ± 0.81 3.41 ± 0.63 0.617
Chocolate and Teaa, Mean ± SD 3.15 ± 0.82 3.21 ± 0.81 2.86 ± 0.79 0.036
Green vegetablesa, Mean ± SD 3.56 ± 0.64 3.56 ± 0.62 3.55 ± 0.78 0.959
Sexb, n (%) 0.150
1 79 (43.17) 70 (45.45) 9 (31.03)
2 104 (56.83) 84 (54.55) 20 (68.97)
Smokingb, n (%) 0.028
0 79 (43.17) 60 (38.96) 19 (65.52)
1 66 (36.07) 59 (38.31) 7 (24.14)
2 38 (20.77) 35 (22.73) 3 (10.34)
Perio statusb, n (%) 0.192
1 53 (28.96) 41 (26.62) 12 (41.38)
2 67 (36.61) 60 (38.96) 7 (24.14)
3 63 (34.43) 53 (34.42) 10 (34.48)
a

Student t-test.

b

Chi-square test.

SD, standard deviation. Bold values indicate P < 0.05.

Multivariable logistic regression showed that higher consumption of Red Meat (Adjusted OR = 0.46, 95% CI: 0.25–0.85, p = 0.013) and Sweets (Adjusted OR = 0.11, 95% CI: 0.05–0.26, p < 0.001) was significantly associated with reduced CVD risk (Figure 7). Whole Grains, Processed Meat, Eggs, Chocolate and Tea, and Total Fruits were also verified as significant protective factors. In contrast, traditional antioxidant sources, including Green Vegetables, Tomatoes, and Citrus Fruits, showed no statistically significant association with CVD outcomes in this specific cohort.

Figure 7.

Bar graph showing multivariable associations of dietary factors with cardiovascular disease (CVD) risk in 183 subjects. Significant protective factors with lower odds ratios include sweets, processed meat, whole grains, red meat, eggs, chocolate and tea, and total fruits. Tomatoes, citrus fruits, and green vegetables show non-significant associations with CVD risk. Error bars denote 95 percent confidence intervals. P-values are given for each factor, with significant findings primarily in the top seven dietary items. Data source and interpretation provided in surrounding text.

Forest plot summarizing the multivariable-adjusted associations between key dietary factors and CVD risk in the external clinical validation cohort (n = 183).

Discussion

Periodontitis represents a pervasive inflammatory burden in the aging population, affecting nearly two-thirds of individuals aged 65 and older (1, 15, 17). In this cohort, the disease acts not merely as a localized oral infection but as a critical, inflammation-driven amplifier of cardiovascular disease (CVD) risk (4, 5). This chronic inflammatory milieu may fundamentally alter the physiological response to dietary patterns, potentially rendering conventional nutritional paradigms—derived from the general population—less applicable (18–20). While NHANES data confirm the link between periodontitis and elevated CVD risk (OR 1.4–2.0) via biomarkers like CRP (5, 21, 22), the interaction between this inflammatory baseline and nutrient metabolism remains poorly understood. We hypothesized that the persistent inflammatory stress of periodontitis modulates metabolic systems, thereby necessitating a re-evaluation of dietary guidelines for this specific demographic.

Traditional linear statistical models are often ill-equipped to capture the high-dimensional, non-linear nutrient interactions inherent to this chronic inflammatory state. By leveraging an interpretable Machine Learning (ML) framework across the NHANES and MPED databases, our XGBoost models achieved high predictive accuracy (AUC-ROC 0.85–0.95) and, crucially, unveiled paradoxical nutrient–CVD relationships. Specifically, SHAP (which calculates the marginal contribution of each feature based on game theory) and LIME (a local surrogate model) provided transparent interpretations, where negative SHAP values explicitly indicated a protective directionality against CVD risk. Contrary to extensive epidemiological evidence linking red/processed meats (via TMAO production) and added sugars (via ROS accumulation) to increased CVD risk (23–26), our SHAP and LIME analyses identified these factors as significantly protective in older adults with periodontitis. This inversion of conventional dietary dogma suggests that the metabolic impact of these food groups is fundamentally reprogrammed by the underlying periodontal inflammation.

This discrepancy likely reflects unique physiological mechanisms driven by “inflammaging.” Periodontitis-induced NLRP3 inflammasome activation and oxidative stress create a distinct metabolic milieu (13, 14), where nutrient utilization may shift from homeostasis to survival. This discrepancy aligns with the established concept of “metabolic reprogramming.” Previous research indicates that the chronic IL-6–driven upregulation of hepcidin disrupts iron metabolism (27). In this inflammatory context, moderate intake of heme iron and zinc from meats may theoretically counteract inflammation-induced anemia and ferroptosis without promoting oxidative stress (28). Similarly, the apparent benefit of sugars might be twofold: first, providing rapid energy substrates to combat the catabolic state associated with chronic infection; and second, when derived from fiber-rich matrices (e.g., fruits), delivering polyphenols that suppress fructosamine formation and modulate the microbiota to reduce gingival NLRP3 activation (29, 30). While residual confounding from health behaviors cannot be ruled out, Mendelian randomization studies support the existence of such non-linear dose–response thresholds in inflammatory subgroups (5, 21).

Our model’s validity is further supported by its corroboration of known cardioprotective nutrients common to the general population. Magnesium emerged as a key protective factor, consistent with its role in endothelial stabilization and NLRP3 inhibition (11, 12, 20, 27). Likewise, the model correctly prioritized Food Folate for its capacity to promote homocysteine remethylation and improve endothelial function (31–33), and Lycopene for its potent ROS-scavenging properties (30, 34, 35). The identification of Beta-Cryptoxanthin and Theobromine aligns with literature demonstrating their lipid-modulating and mortality-reducing effects (36–40). Furthermore, the protective role of whole grains, mediated through fiber–polyphenol synergy (41–43), and the neutral-to-protective effects of eggs (likely due to choline content), indicate that our model captures the nuanced reality where nutrient-dense whole foods retain their essential value even amidst inflammation.

Interestingly, the integration of an external clinical validation cohort (n = 183) extended our findings from theoretical predictions to real-world verification. The clinical data provided supportive evidence of the ML results: red meats and sweets were significantly associated with protective effects, whereas green vegetables did not show statistical significance. This discrepancy reinforces the “metabolic reprogramming” hypothesis. Under the burden of systemic inflammation (e.g., elevated IL-6 and TNF-α), the aging body may prioritize readily available energy and high-quality proteins—such as simple carbohydrates and meat—to counteract the hypermetabolic state induced by chronic inflammation, thereby preserving muscle mass and endothelial resilience (44, 45). In this specific context, the subtle antioxidant effects of vegetables might be overshadowed by the pervasive inflammatory milieu. These findings validate our core argument that dietary guidelines for older adults with periodontitis should be disease-specific rather than a uniform application of general standards.

The primary clinical implication of this work is the necessity for precision nutrition guidelines tailored to periodontitis patients. Simply advising this vulnerable population to adopt a conventional “low-sugar, low-meat” diet may be suboptimal if it fails to account for the metabolic dysregulation caused by their inflammatory burden. Our interpretable ML approach represents a foundational step toward developing nuanced, disease-specific dietary strategies to optimize cardiovascular health in this high-risk group.

Nevertheless, several limitations should be noted. First, the cross-sectional nature of the NHANES data precludes causal inference and risks reverse causation, as the apparent metabolic protection of meat and sweets may merely reflect better masticatory ability rather than true dietary benefits. Second, the 24-h dietary recall method, used to generate both the NHANES micronutrient data and the MPED food group data, may introduce recall bias and underreport episodically consumed foods. Furthermore, methodological heterogeneity exists between the quantitative 24-h recall in NHANES and the frequency-based SQ-FFQ in our validation cohort, which precluded exact threshold calibration and restricted the validation to directional trends rather than absolute intake grams. Third, while the external validation cohort provided crucial clinical verification, its relatively small sample size (n = 183) and low number of CVD cases (n = 29) render the multivariable model underpowered, leading to wide confidence intervals and potential overfitting. Additionally, the external validation cohort lacked adjustment for socioeconomic status, which heavily influences dietary choices and may introduce residual confounding. Finally, although we adjusted for major confounders, the temporal relationship between periodontitis progression and CVD onset cannot be definitively established, and residual confounding from unmeasured factors (e.g., specific oral hygiene practices or statin use) may persist. Therefore, our findings warrant validation in larger, longitudinal, biomarker-based studies designed to prospectively test these unique dietary mechanisms.

Conclusion

By integrating interpretable machine learning with clinical validation, we demonstrate that the chronic systemic inflammatory milieu associated with periodontitis may fundamentally invert established nutrient–CVD risks, rendering conventionally restricted foods—such as red meat and sweets—protective in this specific context. This metabolic divergence underscores the urgent necessity for disease-specific precision nutrition strategies that prioritize metabolic resilience over generic restriction, offering a vital avenue for integrated oral–cardiovascular care that transitions clinical practice from a generalized framework to personalized medicine.

Acknowledgments

Thanks to all authors.

Glossary

Glossary

CVD

Cardiovascular disease

NHANES

National Health and Nutrition Examination Survey

MPED

MyPyramid Equivalents Database

AUC-ROC

Area under the receiver operating characteristic curve

PD

Probing depth

AL

Attachment loss

HR

Hazard ratio

ROS

Reactive oxygen species

ML

Machine learning

SHAP

SHapley Additive exPlanations

LIME

Local Interpretable Model-agnostic Explanations

USDA

United States Department of Agriculture

CDC

Centers for Disease Control and Prevention

AAP

American Academy of Periodontology

BMI

Body mass index

HbA1c

Glycated hemoglobin

OGTT

Oral glucose tolerance test

SMOTE

Synthetic Minority Oversampling Technique

SVM

Support Vector Machine

XGBoost

eXtreme Gradient Boosting

AUC

Area under the curve

PR

Precision-Recall

OR

Odds ratio

CRP

C-reactive protein

TMAO

Trimethylamine N-oxide

SCFA

Short-chain fatty acids

eNOS

Endothelial nitric oxide synthase

HDL

High-density lipoprotein

Funding Statement

The author(s) declared that financial support was not received for this work and/or its publication.

Footnotes

Edited by: Wenhong Deng, Renmin Hospital of Wuhan University, China

Reviewed by: Yu Yao, Zhejiang University School of Medicine, China

Yingzhao Wang, New York University, United States

Data availability statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.

Ethics statement

The studies involving humans were approved by Ethics Committee of Wenzhou Medical University. The studies were conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study.

Author contributions

JL: Conceptualization, Data curation, Formal analysis, Writing – original draft. JW: Writing – original draft, Data curation, Formal analysis, Conceptualization. XN: Data curation, Writing – original draft, Conceptualization. SH: Conceptualization, Writing – review & editing. QX: Conceptualization, Formal analysis, Methodology, Software, Supervision, Data curation, Writing – review & editing, Writing – original draft.

Conflict of interest

The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Generative AI statement

The author(s) declared that Generative AI was not used in the creation of this manuscript.

Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.

Publisher’s note

All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.

Supplementary material

The Supplementary material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fnut.2026.1791821/full#supplementary-material

Image_1.tif (1.2MB, tif)
Image_2.tif (1.2MB, tif)
Image_3.tif (1.2MB, tif)
Table_1.docx (33.6KB, docx)
Table_2.docx (13.8KB, docx)
Table_3.docx (13.4KB, docx)

References

  • 1.Eke PI, Wei L, Borgnakke WS, Thornton-Evans G, Zhang X, Lu H, et al. Periodontitis prevalence in adults ≥ 65 years of age, in the USA. Periodontol. (2016) 72:76–95. doi: 10.1111/prd.12145, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Yang H, Xiao L, Zhang L, Deepal S, Ye G, Zhang X. Epidemic trend of periodontal disease in elderly Chinese population, 1987-2015: a systematic review and meta-analysis. Sci Rep. (2017) 7:45000. doi: 10.1038/srep45000, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.López R, Smith PC, Göstemeyer G, Schwendicke F. Ageing, dental caries and periodontal diseases. J Clin Periodontol. (2017) 44:S145–52. doi: 10.1111/jcpe.12683 [DOI] [PubMed] [Google Scholar]
  • 4.Jang KA, Kim YR, Joo K, Son M. Chronic periodontitis and risk of cerebro-cardiovascular diseases among older Koreans. Gerodontology. (2024) 41:400–8. doi: 10.1111/ger.12722, [DOI] [PubMed] [Google Scholar]
  • 5.Sumayin Ngamdu K, Mallawaarachchi I, Dunipace EA, Chuang LH, Jafri SH, Shah NR, et al. Association between periodontal disease and cardiovascular disease (from the NHANES). Am J Cardiol. (2022) 178:163–8. doi: 10.1016/j.amjcard.2022.05.028, [DOI] [PubMed] [Google Scholar]
  • 6.Bhandari B, Liu Z, Lin S, Macniven R, Akombi-Inyang B, Hall J, et al. Long-term consumption of 10 food groups and cardiovascular mortality: a systematic review and dose response Meta-analysis of prospective cohort studies. Adv Nutr (Bethesda, Md). (2023) 14:55–63. doi: 10.1016/j.advnut.2022.10.010, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Schwingshackl L, Schwedhelm C, Hoffmann G, Lampousi AM, Knüppel S, Iqbal K, et al. Food groups and risk of all-cause mortality: a systematic review and meta-analysis of prospective studies. Am J Clin Nutr. (2017) 105:1462–73. doi: 10.3945/ajcn.117.153148, [DOI] [PubMed] [Google Scholar]
  • 8.Aune D. Plant foods, antioxidant biomarkers, and the risk of cardiovascular disease, cancer, and mortality: a review of the evidence. Adv Nutr (Bethesda, Md). (2019) 10:S404–21. doi: 10.1093/advances/nmz042 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Fang X, Wang K, Han D, He X, Wei J, Zhao L, et al. Dietary magnesium intake and the risk of cardiovascular disease, type 2 diabetes, and all-cause mortality: a dose-response meta-analysis of prospective cohort studies. BMC Med. (2016) 14:210. doi: 10.1186/s12916-016-0742-z, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Micha R, Peñalvo JL, Cudhea F, Imamura F, Rehm CD, Mozaffarian D. Association between dietary factors and mortality from heart disease, stroke, and type 2 diabetes in the United States. JAMA. (2017) 317:912–24. doi: 10.1001/jama.2017.0947, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Zhao L, Hu M, Yang L, Xu H, Song W, Qian Y, et al. Quantitative association between serum/dietary magnesium and cardiovascular disease/coronary heart disease risk: a dose-response meta-analysis of prospective cohort studies. J Cardiovasc Pharmacol. (2019) 74:516–27. doi: 10.1097/FJC.0000000000000739, [DOI] [PubMed] [Google Scholar]
  • 12.Behers BJ, Behers BM, Stephenson-Moe CA, Vargas IA, Meng Z, Thompson AJ, et al. Magnesium and potassium supplementation for systolic blood pressure reduction in the general normotensive population: a systematic review and subgroup Meta-analysis for optimal dosage and treatment length. Nutrients. (2024) 16:3617. doi: 10.3390/nu16213617, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13.Kurita-Ochiai T, Jia R, Cai Y, Yamaguchi Y, Yamamoto M. Periodontal disease-induced atherosclerosis and oxidative stress. Antioxidants (Basel, Switzerland). (2015) 4:577–90. doi: 10.3390/antiox4030577, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14.Paul O, Arora P, Mayer M, Chatterjee S. Inflammation in periodontal disease: possible link to vascular disease. Front Physiol. (2020) 11:609614. doi: 10.3389/fphys.2020.609614 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Eke PI, Dye BA, Wei L, Slade GD, Thornton-Evans GO, Borgnakke WS, et al. Update on prevalence of periodontitis in adults in the United States: NHANES 2009 to 2012. J Periodontol. (2015) 86:611–22. doi: 10.1902/jop.2015.140520, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16.Chen Z, Chen J, Collins R, Guo Y, Peto R, Wu F, et al. China Kadoorie biobank of 0.5 million people: survey methods, baseline characteristics and long-term follow-up. Int J Epidemiol. (2011) 40:1652–66. doi: 10.1093/ije/dyr120, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 17.Papapanou PN. The prevalence of periodontitis in the US: forget what you were told. J Dent Res. (2012) 91:907–8. doi: 10.1177/0022034512458692, [DOI] [PubMed] [Google Scholar]
  • 18.An P, Wan S, Luo Y, Luo J, Zhang X, Zhou S, et al. Micronutrient supplementation to reduce cardiovascular risk. J Am Coll Cardiol. (2022) 80:2269–85. doi: 10.1016/j.jacc.2022.09.048, [DOI] [PubMed] [Google Scholar]
  • 19.Schwingshackl L, Boeing H, Stelmach-Mardas M, Gottschald M, Dietrich S, Hoffmann G, et al. Dietary supplements and risk of cause-specific death, cardiovascular disease, and Cancer: a systematic review and Meta-analysis of primary prevention trials. Adv Nutr (Bethesda, Md). (2017) 8:27–39. doi: 10.3945/an.116.013516, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20.Zhang X, Li Y, Del Gobbo LC, Rosanoff A, Wang J, Zhang W, et al. Effects of magnesium supplementation on blood pressure: a meta-analysis of randomized double-blind placebo-controlled trials. Hypertension. (2016) 68:324–33. doi: 10.1161/HYPERTENSIONAHA.116.07664, [DOI] [PubMed] [Google Scholar]
  • 21.Shi W, Huang X, Schooling CM, Zhao JV. Red meat consumption, cardiovascular diseases, and diabetes: a systematic review and meta-analysis. Eur Heart J. (2023) 44:2626–35. doi: 10.1093/eurheartj/ehad336, [DOI] [PubMed] [Google Scholar]
  • 22.Zeraatkar D, Han MA, Guyatt GH, Vernooij RWM, El Dib R, Cheung K, et al. Red and processed meat consumption and risk for all-cause mortality and cardiometabolic outcomes: a systematic review and meta-analysis of cohort studies. Ann Intern Med. (2019) 171:703–10. doi: 10.7326/M19-0655, [DOI] [PubMed] [Google Scholar]
  • 23.Wang M, Wang Z, Lee Y, Lai HTM, de Oliveira Otto MC, Lemaitre RN, et al. Dietary meat, trimethylamine N-oxide-related metabolites, and incident cardiovascular disease among older adults: the cardiovascular health study. Arterioscler Thromb Vasc Biol. (2022) 42:e273–88. doi: 10.1161/ATVBAHA.121.316533, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Chen H, Kong J, Du P, Wang Q, Jiang T, Hou X, et al. Functional metabolomics: unlocking the role of small molecular metabolites. Front Mol Biosci. (2025) 12:1542100. doi: 10.3389/fmolb.2025.1542100, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Yang Q, Zhang Z, Gregg EW, Flanders WD, Merritt R, Hu FB. Added sugar intake and cardiovascular diseases mortality among US adults. JAMA Intern Med. (2014) 174:516–24. doi: 10.1001/jamainternmed.2013.13563, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26.Kundu N, Domingues CC, Patel J, Aljishi M, Ahmadi N, Fakhri M, et al. Sucralose promotes accumulation of reactive oxygen species (ROS) and adipogenesis in mesenchymal stromal cells. Stem Cell Res Ther. (2020) 11:250. doi: 10.1186/s13287-020-01753-0, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Bagheri A, Naghshi S, Sadeghi O, Larijani B, Esmaillzadeh A. Total, dietary, and supplemental magnesium intakes and risk of all-cause, cardiovascular, and Cancer mortality: a systematic review and dose-response Meta-analysis of prospective cohort studies. Adv Nutr (Bethesda, Md). (2021) 12:1196–210. doi: 10.1093/advances/nmab001, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 28.Zhang B, Zhao Q, Guo W, Bao W, Wang X. Association of whole grain intake with all-cause, cardiovascular, and cancer mortality: a systematic review and dose-response meta-analysis from prospective cohort studies. Eur J Clin Nutr. (2018) 72:57–65. doi: 10.1038/ejcn.2017.149, [DOI] [PubMed] [Google Scholar]
  • 29.Krittanawong C, Narasimhan B, Wang Z, Virk HUH, Farrell AM, Zhang H, et al. Association between egg consumption and risk of cardiovascular outcomes: a systematic review and meta-analysis. Am J Med. (2021) 134:76–83.e2. doi: 10.1016/j.amjmed.2020.05.046, [DOI] [PubMed] [Google Scholar]
  • 30.Cheng HM, Koutsidis G, Lodge JK, Ashor A, Siervo M, Lara J. Tomato and lycopene supplementation and cardiovascular risk factors: a systematic review and meta-analysis. Atherosclerosis. (2017) 257:100–8. doi: 10.1016/j.atherosclerosis.2017.01.009, [DOI] [PubMed] [Google Scholar]
  • 31.Dong J, Li Z, Wang C, Zhang R, Li Y, Liu M, et al. Dietary folate intake and all-cause mortality and cardiovascular mortality in American adults with non-alcoholic fatty liver disease: data from NHANES 2003 to 2018. PLoS One. (2024) 19:e0314148. doi: 10.1371/journal.pone.0314148, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Zhang B, Dong H, Xu Y, Xu D, Sun H, Han L. Associations of dietary folate, vitamin B6 and B12 intake with cardiovascular outcomes in 115664 participants: a large UK population-based cohort. Eur J Clin Nutr. (2023) 77:299–307. doi: 10.1038/s41430-022-01206-2, [DOI] [PubMed] [Google Scholar]
  • 33.Huang J, Khatun P, Xiong Y, Liu B, Zhao Y, Lyu Q. Intakes of folate, vitamin B6, and vitamin B12 and cardiovascular disease risk: a national population-based cross-sectional study. Front Cardiovasc Med. (2023) 10:1237103. doi: 10.3389/fcvm.2023.1237103, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34.Li N, Wu X, Zhuang W, Xia L, Chen Y, Wu C, et al. Tomato and lycopene and multiple health outcomes: umbrella review. Food Chem. (2021) 343:128396. doi: 10.1016/j.foodchem.2020.128396, [DOI] [PubMed] [Google Scholar]
  • 35.Zamani M, Behmanesh Nia F, Ghaedi K, Mohammadpour S, Amirani N, Goudarzi K, et al. The effects of lycopene and tomato consumption on cardiovascular risk factors in adults: a grade assessment systematic review and meta-analysis. Curr Pharm Des. (2023) 29:1671–700. doi: 10.2174/1381612829666230726112510, [DOI] [PubMed] [Google Scholar]
  • 36.Tierney AC, Rumble CE, Billings LM, George ES. Effect of dietary and supplemental lycopene on cardiovascular risk factors: a systematic review and Meta-analysis. Adv Nutr (Bethesda, Md). (2020) 11:1453–88. doi: 10.1093/advances/nmaa069, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37.Cheng HM, Koutsidis G, Lodge JK, Ashor AW, Siervo M, Lara J. Lycopene and tomato and risk of cardiovascular diseases: a systematic review and meta-analysis of epidemiological evidence. Crit Rev Food Sci Nutr. (2019) 59:141–58. doi: 10.1080/10408398.2017.1362630, [DOI] [PubMed] [Google Scholar]
  • 38.Qiu Z, Chen X, Geng T, Wan Z, Lu Q, Li L, et al. Associations of serum carotenoids with risk of cardiovascular mortality among individuals with type 2 diabetes: results from NHANES. Diabetes Care. (2022) 45:1453–61. doi: 10.2337/dc21-2371, [DOI] [PubMed] [Google Scholar]
  • 39.Zhu X, Cheang I, Tang Y, Shi M, Zhu Q, Gao R, et al. Associations of serum carotenoids with risk of all-cause and cardiovascular mortality in hypertensive adults. J Am Heart Assoc. (2023) 12:e027568. doi: 10.1161/jaha.122.027568, [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Lin B, Liu Z, Li D, Zhang T, Yu C. Associations of serum carotenoids with all-cause and cardiovascular mortality in adults with MAFLD. Nutr Metab Cardiovasc Dis. (2024) 34:2315–24. doi: 10.1016/j.numecd.2024.06.001, [DOI] [PubMed] [Google Scholar]
  • 41.Sharifi-Zahabi E, Hajizadeh-Sharafabad F, Nachvak SM, Mirzaian S, Darbandi S, Shidfar F. A comprehensive insight into the molecular effect of theobromine on cardiovascular-related risk factors: a systematic review of in vitro and in vivo studies. Phytother Res. (2023) 37:3765–79. doi: 10.1002/ptr.7916, [DOI] [PubMed] [Google Scholar]
  • 42.Berends LM, van der Velpen V, Cassidy A. Flavan-3-ols, theobromine, and the effects of cocoa and chocolate on cardiometabolic risk factors. Curr Opin Lipidol. (2015) 26:10–9. doi: 10.1097/MOL.0000000000000144, [DOI] [PubMed] [Google Scholar]
  • 43.Wei H, Gao Z, Liang R, Li Z, Hao H, Liu X. Whole-grain consumption and the risk of all-cause, CVD and cancer mortality: a meta-analysis of prospective cohort studies. Br J Nutr. (2016) 116:514–25. doi: 10.1017/S0007114516001975, [DOI] [PubMed] [Google Scholar]
  • 44.Deutz NE, Bauer JM, Barazzoni R, Biolo G, Boirie Y, Bosy-Westphal A, et al. Protein intake and exercise for optimal muscle function with aging: recommendations from the ESPEN expert group. Clin Nutr. (2014) 33:929–36. doi: 10.1016/j.clnu.2014.04.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Straub RH. Insulin resistance, selfish brain, and selfish immune system: an evolutionarily positively selected program used in chronic inflammatory diseases. Arthritis Res Ther. (2014) 16:S4. doi: 10.1186/ar4688 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Image_1.tif (1.2MB, tif)
Image_2.tif (1.2MB, tif)
Image_3.tif (1.2MB, tif)
Table_1.docx (33.6KB, docx)
Table_2.docx (13.8KB, docx)
Table_3.docx (13.4KB, docx)

Data Availability Statement

The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.


Articles from Frontiers in Nutrition are provided here courtesy of Frontiers Media SA

RESOURCES